Journal of Nanoscience and Nanotechnology 2014-07-01

A lucid build-up of nanostructured curcumin, quercetin and their interaction with DNA.

Marichamy Rajasekaran, Jamespandi Annaraj

Index: J. Nanosci. Nanotechnol. 14(7) , 4874-9, (2014)

Full Text: HTML

Abstract

Nanostructured phyto-drugs such as curcumin and quercetin were prepared by simple sonochemical method and studied for their bio-activities. FT-IR spectra indicate that the chemical structures of these nanostructured drugs are identical with their commercially available microcrystalline counterparts. Scanning Electron Microscopic (SEM) analysis reveals that the curcumin and quercetin, form as nanocube and nanoneedle like structures respectively. These nanocrystalline drugs have enhanced solubility in neutral aqueous medium at room temperature and thus exhibit better bioavailability than their commercially available microcrystalline form. Their DNA interactions and the observed binding constants were investigated through UV-vis spectral technique. Nanocurcumin, due to its small size, exhibits significantly high DNA binding constant (1.2 x 10(6) M(-1)). The voltammetric and CD spectral changes observed for the nanocurcumin reveal its deep penetration into the core of the DNA through the minor grooves, where it forms H-bonds with the floor nitrogen/oxygen atoms of the DNA bases.


Related Compounds

  • Curcumin
  • deoxyribonucleic a...
  • Deoxyribonucleic a...
  • Deoxyribonucleic a...
  • Quercetin

Related Articles:

Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release.

2014-11-01

[J. Pharm. Sci. 103(11) , 3764-71, (2014)]

Enhancing the anti-inflammatory activity of chalcones by tuning the Michael acceptor site.

2015-03-14

[Org. Biomol. Chem. 13(10) , 3040-7, (2015)]

An antifungal mechanism of curcumin lies in membrane-targeted action within Candida albicans.

2014-11-01

[IUBMB Life 66(11) , 780-5, (2015)]

Identification of the cellular mechanisms that modulate trafficking of frizzled family receptor 4 (FZD4) missense mutants associated with familial exudative vitreoretinopathy.

2014-06-01

[Invest. Ophthalmol. Vis. Sci. 55(6) , 3423-31, (2014)]

Improved plasma membrane expression of the trafficking defective P344R mutant of muscle, skeletal, receptor tyrosine kinase (MuSK) causing congenital myasthenic syndrome.

2015-03-01

[Int. J. Biochem. Cell Biol. 60 , 119-29, (2015)]

More Articles...